Takeda Pharmaceutical Company Limited is to invest €40m

Takeda Pharmaceutical Company Limited is to invest €40m in a new facility at their Grange Castle site in Dublin.

Takeda is the largest pharmaceutical company in Japan and a global industry leader. The company first set up operations in Ireland in 1997 manufacturing products for global markets. In 2002, Takeda chose Dublin as the location for its first active pharmaceutical ingredient (API) facility outside of Japan.

The investment by Takeda will expand their Grange Castle site’s existing footprint with the construction of a new standalone high containment production facility dedicated to manufacturing its oncology product NINLAROTM for global markets. The investment will create approximately 40 new jobs.

“We are delighted that Takeda has chosen Ireland for this investment and proud that we have been entrusted with the responsibility to produce and deliver this very important treatment for cancer patients worldwide. We have a great team here in Ireland and are committed to continuing to put patients first through the timely manufacture and supply of high quality products from our site”.

Mr. Paul Keogh, Plant Director at Takeda Ireland Grange Castle

Mike Morissey

(Director) MRGC, MRMC, MCIPD – Cork Office

Mike Morrissey has extensive knowledge of production, quality and engineering, having worked for Dell, Creative Labs and Tyco Safety Products /Sensormatic.

His expansive operational experience is grounded with training as a Six Sigma Black Belt.

As a lead auditor, he is very familiar with compliance and quality standards and has project managed the implementation of the environmental standard ISO14001. He has successfully utilised his project management and team leading skills in implementing numerous cost-saving and process improvement projects.

Since joining CareerWise Recruitment, Mike has graduated with a Diploma in Personnel Management from UCC and is a Chartered member of the CIPD.

Tags: